๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Aggression

Prostate Tissue BioBank NCT06659614n/a1 site๐Ÿ“ Philadelphia Abramson Cancer Center at Penn Medicine The Effect on Adolescents' Cyberbullying/Cyber Victimization and Coping Skills of the Human Values-Oriented Cyberbullying Prevention Program NCT07443748NA2 sites๐Ÿ“ Adana๐Ÿ“ Adana Pelin Bรผyรผksandฤฑรง ร–zลŸen ยท Tests: Human Values-Oriented Cyberbullying Prevention Program Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma NCT07704918NA1 site๐Ÿ“ Aurora University of Colorado, Denver ยท Tests: Statins (atorvastatin, rosuvastatin, simvastatin, or pravastatin), +/- ezetimibe, +/- PCSK9 inhibitor (alirocumab, evolโ€ฆ SynKIR-310 for Relapsed/Refractory B-NHL NCT06544265Phase 15 sites๐Ÿ“ Denver๐Ÿ“ Atlanta๐Ÿ“ Fairway Verismo Therapeutics ยท Tests: SynKIR-310 Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing NCT06550427n/a1 site๐Ÿ“ Taipei National Taiwan University Hospital ยท Tests: ctDNA analyzed by phased variant Treatment of Chronic Anger and Aggression Following Military-Related Betrayal NCT06609330NA1 site๐Ÿ“ Fort Cavazos The University of Texas Health Science Center at San Antonio ยท Tests: Countering Chronic Anger and Aggression Related to Trauma and Transgressions (CART) Refinements of Functional Communication Training NCT04045600NA1 site๐Ÿ“ Somerset Rutgers, The State University of New Jersey ยท Tests: Trad FCT, Mult FCT, Mult FCT + Stimulus Fading Zanzalintinib in Men With Aggressive Variant Prostate Cancer NCT07218666Phase 21 site๐Ÿ“ Milwaukee Deepak Kilari ยท Tests: Zanzalintinib GVMยฑR in Patients With Relapsed or Refractory Aggressive NHL. NCT06244368Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: GVMยฑR regimen Addressing Root Causes for Gun Violence Prevention (ARC-GVP) NCT05887973n/a1 site๐Ÿ“ Ann Arbor University of Michigan ยท Tests: The T.R.I.G.G.E.R Project Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma NCT05077527Phase 17 sites๐Ÿ“ Duarte๐Ÿ“ Chicago๐Ÿ“ New York AIDS Malignancy Consortium ยท Tests: Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients NCT03048266n/a1 site๐Ÿ“ Houston M.D. Anderson Cancer Center Transgender Men, Non-binary Persons and Testosterone Treatment BODY IDENTITY CLINIC NCT04254354n/a1 site๐Ÿ“ Odense Marianne Andersen Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated With CNS Stimulants NCT06871488Phase 41 site๐Ÿ“ Hershey Milton S. Hershey Medical Center ยท Tests: CNS Stimulant, Placebo, CNS Stimulant open label first phase The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies NCT04329728Phase 1, Phase 211 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles AVM Biotechnology Inc ยท Tests: AVM0703 Effect of Nitrous Oxide on Aggression. NCT06118567Phase 21 site๐Ÿ“ Columbus Ohio State University ยท Tests: Nitrous oxide, Room Air Trauma-Informed Peer Aggression and Dating Violence Prevention for Preteens Receiving Intensive Mental Health Services NCT06769282NA1 site๐Ÿ“ Providence Rhode Island Hospital ยท Tests: Experimental: Intervention (SPARE) plus Treatment as Usual, Treatment as Usual (TAU) Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) NCT07197307Phase 234 sites๐Ÿ“ Aachen๐Ÿ“ Augsburg๐Ÿ“ Berlin Universitรคt Mรผnster ยท Tests: Loncastuximab Tesirine and Epcoritamab Momentary Coping Prompts and Hair Steroids in College Students NCT07782398NA1 site๐Ÿ“ Gainesville University of Florida ยท Tests: Momentary coping prompt, Active control message Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism NCT07091279Phase 22 sites๐Ÿ“ Staten Island๐Ÿ“ White Plains Jeremy Veenstra-vanderweele ยท Tests: Propranolol, Placebo Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma NCT06536049Phase 1, Phase 23 sites๐Ÿ“ Minneapolis๐Ÿ“ Columbus๐Ÿ“ Richmond Yazeed Sawalha ยท Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography, Epcoritamab Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ฮถ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL) NCT03938987Phase 1, Phase 26 sites๐Ÿ“ Calgary๐Ÿ“ Calgary๐Ÿ“ Calgary University of Alberta ยท Tests: autologous CD19-directed chimeric antigen receptor (CAR) T-cells Efficacy of a Multi-level School Intervention for LGBTQ Youth NCT05541406NA23 sites๐Ÿ“ El Monte๐Ÿ“ El Monte๐Ÿ“ El Monte Washington University School of Medicine ยท Tests: Proud & Empowered, Control Group Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy NCT06834373Phase 27 sites๐Ÿ“ Scottsdale๐Ÿ“ Jacksonville๐Ÿ“ Albert Lea Mayo Clinic ยท Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Chimeric Antigen Receptor T-Cell Therapy, Computed โ€ฆ Predictive Factors for Survival in Aggressive Meningiomas NCT05793034NA1 site๐Ÿ“ Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: Biological biomarker assessment Plaque Reversal With Early, Aggressive Lipid Lowering Therapy NCT05783804n/a1 site๐Ÿ“ Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AMโ€ฆ Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia NCT05863234Phase 1, Phase 21 site๐Ÿ“ Hiroshima Hiroshima University Hospital ยท Tests: PPMX-T003 Assessment of Safety and Efficacy of IM19 for Recurrent or Refractory (R/R) Non-Hodgkin's Lymphoma(NHL) Patients NCT04440436Phase 1, Phase 21 site๐Ÿ“ Beijing Beijing Immunochina Medical Science & Technology Co., Ltd. ยท Tests: IM19 CAR-T Cells CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL). NCT05260957Phase 21 site๐Ÿ“ Miami Lazaros Lekakis ยท Tests: Mosunetuzumab, Polatuzumab, CAR-T Cell Therapy Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy NCT06238648Phase 26 sites๐Ÿ“ Rochester๐Ÿ“ St Louis๐Ÿ“ Hackensack Academic and Community Cancer Research United ยท Tests: Biopsy, Biospecimen Collection, Computed Tomography, Epcoritamab, Magnetic Resonance Imaging
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy